Friday - April 19, 2024

Category Archives: Pharmaceuticals & Biotech

Checkpoint Inhibitor Refractory Cancer Market Size in the 7MM is anticipated to grow by 2032 | DelveInsight

DelveInsight’s ‘Checkpoint Inhibitor Refractory Cancer Market Insights, Epidemiology, and Market Forecast—2032’ report delivers an in-depth understanding of the Checkpoint Inhibitor Refractory Cancer, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, … Continue reading →

Catheter-Related Bloodstream Infection Market Size in the 7MM is anticipated to grow by 2032 | DelveInsight

DelveInsight’s “Catheter-Related Bloodstream Infection Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Catheter-Related Bloodstream Infection (CRBSI), historical and forecasted epidemiology as well as the Catheter-Related Bloodstream Infection (CRBSI) market trends in the United States, EU5 … Continue reading →

Pertussis Market Analysis 2032: Epidemiology, FDA Approvals, Clinical Trials, Therapies, Companies by DelveInsight | Sanofi Pasteur, Mitsubishi Tanabe Pharma, GlaxoSmithKline, ILiAD Biotechnologies

Pertussis Market Pertussis companies are Sanofi Pasteur, Mitsubishi Tanabe Pharma, GlaxoSmithKline, ILiAD Biotechnologies, Serum Institute, Bilthoven, Vakzine Projekt Management GmbH (VPM), Cansino Bio, China National Biotec Group and Beijing Institute of Biological Products, and others. DelveInsight’s “Pertussis Market Insights, Epidemiology, … Continue reading →

Hypertriglyceridemia Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Ionis Pharma, 89bio, Inc., Arrowhead Pharma, Hightide Therapeutics, Eli Lilly

The Hypertriglyceridemia Market size was valued approximately USD 2,400 million in 2022 and the report offers an in-depth understanding of the Hypertriglyceridemia, historical and forecasted epidemiology as well as the Hypertriglyceridemia market trends in the 7MM. DelveInsight’s “Hypertriglyceridemia Market Insights, … Continue reading →

Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2024-2034), States DelveInsight

The Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) Market size was valued approximately USD 1,263 million in 2022 and the report offers an in-depth understanding of the Pulmonary Hypertension Associated with Interstitial Lung Disease, historical and forecasted epidemiology as … Continue reading →